(RTTNews) - European stocks advanced on Monday as falling oil prices eased inflation concerns and German Chancellor Friedrich Merz vowed to press ahead with reforms after suffering a bruising electoral setback in two st…
(RTTNews) - AstraZeneca (AZN), a biopharmaceutical company, said the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has recommended approval of Enhertu for an additional early breast c…
(RTTNews) - Pure Tech Health (PRTC) said the U.S. FDA has completed its End-of Phase 1 review of LYT-200 and granted the experimental therapy Fast Track designation for the treatment of relapsed/refractory high-risk mye…
(RTTNews) - Solidion Technology Inc. (STI), an advanced battery technology solutions provider, announced that it appointed Chief Executive Officer Jaymes Winters to also serve as Chairman of the Board, effective immedia…
(RTTNews) - The Australian market is trimming its early losses in mid-market moves on Thursday, giving up the gains in the previous two sessions, despite the broadly positive cues from Wall Street overnight. The benchma…
The nationwide data center build-out continues, though rife with politics. Here we highlight 2 microcaps that may benefit. Tredegar Corporation (TG) is a manufacturing company engaged, through its subsidiaries, in the p…
(RTTNews) - Telix Pharmaceuticals (TLX) has agreed to merge with ITM Isotope Technologies Munich SE, a company specializing in radioisotope production and radiopharmaceutical development, in a transaction designed to ex…
(RTTNews) - Abbisko Therapeutics Co., Ltd. (02256.HK) announced positive preliminary Phase II results for avengratinib (ABSK061), used for the treatment for achondroplasia, a genetic condition that affects bone growth a…
The VanEck Semiconductor ETF beat the S&P 500 on total return in eight of the 10 calendar years from 2016 through 2025.
The past few years have been challenging for Pfizer (NYSE: PFE). The company has faced macroeconomic problems, significantly lower sales from its coronavirus portfolio, and looming patent cliffs, including for its best-…
Headlines about the risks of advances in artificial intelligence are getting more attention.
Shares currently hover around their opening-day price, supported by optimism around the company's artificial intelligence (AI) growth.
IonQ's revenue rose 287% in the second quarter, but the company's recently updated full-year sales guidance leans heavily on a recent acquisition.
Since 1985, the S&P 500 has risen in 34 of 41 fourth quarters, averaging a gain of about 4.4% -- the best record of the year's four quarters.
The Vanguard Total Bond Market ETF has historically returned around 3% annually since its inception in 2007.
Nvidia has generated enormous levels of earnings thanks to its AI chip business.
Even if it’s not being officially reported yet, its drug Casgevy is accruing revenue that will show up in earnest beginning next year.
After subtracting out the values of its cash pile and the Anthropic investment, Zoom's enterprise value is much lower than investors would expect.
But, it's still very reasonable to expect this coin to continue to grow significantly over time.
The state assembly recently amended wildfire reform legislation, potentially opening the doors for insurance companies to sue companies like PG&E.
The new Apple iPhone 18 hit the market on Friday, but it's saving a premium-priced surprise for next month.
Although the Dow Jones Industrial Average, S&P 500, and Nasdaq Composite reached new highs in 2026, history shows bull markets aren’t indefinite.
Coca-Cola is a Dividend King, with 64 years of consecutive annual dividend increases.
Access to capital markets can dry up, harming Wall Street sentiment toward the company.
